E
Theralase Technologies Inc.
TLTFF
$0.1293
$0.00131.02%
E
Sell
3/20/2025Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 3/20/2025 due to a decline in the total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 3/20/2025 due to a decline in the total return index and volatility index.
D
Sell
12/20/2024Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 12/20/2024 due to an increase in the volatility index, total return index and valuation index.
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 12/20/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
11/29/2024Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 11/29/2024 due to a decline in the volatility index and total return index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 11/29/2024 due to a decline in the volatility index and total return index.
D
Sell
11/21/2024Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 11/21/2024 due to an increase in the total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 11/21/2024 due to an increase in the total return index and volatility index.
E
Sell
11/6/2024Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 11/6/2024 due to a decline in the volatility index, valuation index and growth index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 11/6/2024 due to a decline in the volatility index, valuation index and growth index.
D
Sell
10/21/2024Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 10/21/2024 due to an increase in the volatility index.
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 10/21/2024 due to an increase in the volatility index.
E
Sell
3/21/2024Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 3/21/2024 due to a decline in the volatility index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 3/21/2024 due to a decline in the volatility index.
D
Sell
3/4/2024Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 3/4/2024 due to an increase in the growth index and volatility index. Operating cash flow increased 46.96% from -$835.6 to -$443.2, total revenue increased 28.34% from $163 to $209.2, and earnings per share increased from -$0.004 to -$0.0035.
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 3/4/2024 due to an increase in the growth index and volatility index. Operating cash flow increased 46.96% from -$835.6 to -$443.2, total revenue increased 28.34% from $163 to $209.2, and earnings per share increased from -$0.004 to -$0.0035.
E
Sell
9/20/2023Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 9/20/2023 due to a major decline in the solvency index, total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 9/20/2023 due to a major decline in the solvency index, total return index and volatility index.
D
Sell
3/14/2023Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 02/23/2023.
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, solvency index and volatility index. Total revenue declined 25.21% from $267 to $199.7, EBIT declined 9.04% from -$976.7 to -$1.07M, and earnings per share declined from -$0.0048 to -$0.0052.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, solvency index and volatility index. Total revenue declined 25.21% from $267 to $199.7, EBIT declined 9.04% from -$976.7 to -$1.07M, and earnings per share declined from -$0.0048 to -$0.0052.
D
Sell
4/29/2022Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 4/29/2022 due to an increase in the valuation index.
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 4/29/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index and solvency index. The quick ratio declined from 7.14 to 6.34.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index and solvency index. The quick ratio declined from 7.14 to 6.34.
D
Sell
11/9/2021Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from E+ on 11/09/2021.
Theralase Technologies Inc. (TLTFF) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
2/8/2021Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 2/8/2021 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 35.3% from -$921.9 to -$596.5, total revenue increased 33.82% from $131.3 to $175.7, and EBIT increased 8.36% from -$1.19M to -$1.09M.
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 2/8/2021 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 35.3% from -$921.9 to -$596.5, total revenue increased 33.82% from $131.3 to $175.7, and EBIT increased 8.36% from -$1.19M to -$1.09M.
D
Sell
4/30/2020Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 4/30/2020 due to a substantial decline in the efficiency index, growth index and solvency index. EBIT declined 69.29% from -$1.35M to -$2.29M, net income declined 68.79% from -$1.35M to -$2.28M, and earnings per share declined from -$0.0094 to -$0.0156.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 4/30/2020 due to a substantial decline in the efficiency index, growth index and solvency index. EBIT declined 69.29% from -$1.35M to -$2.29M, net income declined 68.79% from -$1.35M to -$2.28M, and earnings per share declined from -$0.0094 to -$0.0156.
D
Sell
11/29/2019Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 11/29/2019 due to a significant increase in the efficiency index, solvency index and valuation index. The quick ratio increased from 1.59 to 18.27, total capital increased 508.42% from $2.08M to $12.67M, and debt to equity declined from 0.02 to 0.
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 11/29/2019 due to a significant increase in the efficiency index, solvency index and valuation index. The quick ratio increased from 1.59 to 18.27, total capital increased 508.42% from $2.08M to $12.67M, and debt to equity declined from 0.02 to 0.
D
Sell
5/31/2019Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 5/31/2019 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 346.98% from -$432.7 to -$1.93M, total revenue declined 73.72% from $346.6 to $91.1, and net income declined 50% from -$564.2 to -$846.3.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 5/31/2019 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 346.98% from -$432.7 to -$1.93M, total revenue declined 73.72% from $346.6 to $91.1, and net income declined 50% from -$564.2 to -$846.3.
D
Sell
4/18/2019Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 4/18/2019 due to a noticeable increase in the total return index, efficiency index and solvency index. Total capital increased 69.85% from $430.9 to $731.9, and the quick ratio increased from 0.56 to 0.71.
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 4/18/2019 due to a noticeable increase in the total return index, efficiency index and solvency index. Total capital increased 69.85% from $430.9 to $731.9, and the quick ratio increased from 0.56 to 0.71.
D
Sell
2/19/2019Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 2/19/2019 due to a noticeable increase in the total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 2/19/2019 due to a noticeable increase in the total return index and volatility index.
E
Sell
2/4/2019Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 2/4/2019 due to a decline in the total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 2/4/2019 due to a decline in the total return index and volatility index.
D
Sell
1/18/2019Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 1/18/2019 due to an increase in the total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was upgraded to D- from E+ on 1/18/2019 due to an increase in the total return index and volatility index.
E
Sell
12/31/2018Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 12/31/2018 due to a significant decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.62 to 0.56.
Theralase Technologies Inc. (TLTFF) was downgraded to E+ from D- on 12/31/2018 due to a significant decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.62 to 0.56.
D
Sell
3/11/2016Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 3/11/2016 due to a noticeable decline in the volatility index, efficiency index and valuation index. Net income declined 37.84% from -$1.09M to -$1.51M, and total capital declined 26.31% from $6.71M to $4.94M.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 3/11/2016 due to a noticeable decline in the volatility index, efficiency index and valuation index. Net income declined 37.84% from -$1.09M to -$1.51M, and total capital declined 26.31% from $6.71M to $4.94M.
D
Sell
8/28/2015Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D from D+ on 8/28/2015 due to a noticeable decline in the efficiency index, growth index and total return index. Total revenue declined 15.16% from $296.8 to $251.8, and total capital declined 12.41% from $7.66M to $6.71M.
Theralase Technologies Inc. (TLTFF) was downgraded to D from D+ on 8/28/2015 due to a noticeable decline in the efficiency index, growth index and total return index. Total revenue declined 15.16% from $296.8 to $251.8, and total capital declined 12.41% from $7.66M to $6.71M.
D
Sell
7/21/2015Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D+ from D on 7/21/2015 due to an increase in the valuation index.
Theralase Technologies Inc. (TLTFF) was upgraded to D+ from D on 7/21/2015 due to an increase in the valuation index.
D
Sell
7/6/2015Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D from D+ on 7/6/2015 due to a decline in the total return index.
Theralase Technologies Inc. (TLTFF) was downgraded to D from D+ on 7/6/2015 due to a decline in the total return index.
D
Sell
6/8/2015Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D+ from D on 6/8/2015 due to a major increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 4.99 to 19.18, total capital increased 168.21% from $2.85M to $7.66M, and net income increased 0.53% from -$748.3 to -$752.3.
Theralase Technologies Inc. (TLTFF) was upgraded to D+ from D on 6/8/2015 due to a major increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 4.99 to 19.18, total capital increased 168.21% from $2.85M to $7.66M, and net income increased 0.53% from -$748.3 to -$752.3.
D
Sell
11/12/2014Upgraded
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 11/12/2014 due to an increase in the total return index and volatility index.
Theralase Technologies Inc. (TLTFF) was upgraded to D from D- on 11/12/2014 due to an increase in the total return index and volatility index.
D
Sell
9/24/2014Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 9/24/2014 due to a large decline in the volatility index and total return index.
Theralase Technologies Inc. (TLTFF) was downgraded to D- from D on 9/24/2014 due to a large decline in the volatility index and total return index.
D
Sell
9/3/2014Downgrade
Theralase Technologies Inc. (TLTFF) was downgraded to D from D+ on 9/3/2014 due to a major decline in the efficiency index, volatility index and total return index.
Theralase Technologies Inc. (TLTFF) was downgraded to D from D+ on 9/3/2014 due to a major decline in the efficiency index, volatility index and total return index.
OTC PK
04/04/2025 12:49PM Eastern
Quotes delayed
